Pfizer-AstraZeneca deal? Not as crazy as it sounds
April 21, 2014 at 18:24 PM EDT
Yes, it's possibly among the biggest pharma deals ever and it's $101 billion more than half of Pfizer's market cap. Yet, analysts cite reasons to buy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|